Ángel Zarain-Herzberg

Ángel Zarain-Herzberg

Auto-generated profile, based on publicly available information

Ángel Zarain-Herzberg

Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, Av. Universidad 3000 SN, Colonia UNAM, CU, Ciudad de México 04510, México

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Cell Calcium
Verified
Journal Article
Closed access
AZAngel Zarain-Herzberg
Angel Zarain-Herzberg
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas
RERafael Estrada-Avilés
Rafael Estrada-Avilés

1 August 2019 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
EIEduardo Izquierdo-Torres
Eduardo Izquierdo-Torres
AHAndrés Hernández-Oliveras
Andrés Hernández-Oliveras
IMIván Meneses-Morales
Iván Meneses-Morales
GRGabriela Rodríguez
Gabriela Rodríguez
GFGabriela Fuentes-García
Gabriela Fuentes-García
ÁZÁngel Zarain-Herzberg
Ángel Zarain-Herzberg

7 September 2011 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
AZAngel Zarain‐Herzberg
Angel Zarain‐Herzberg
JFJorge Fragoso‐Medina
Jorge Fragoso‐Medina
RERafael Estrada‐Avilés
Rafael Estrada‐Avilés

2 February 2017 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
EIEduardo Izquierdo‐Torres
Eduardo Izquierdo‐Torres
GRGabriela Rodríguez
Gabriela Rodríguez
IMIván Meneses-Morales
Iván Meneses-Morales
AZAngel Zarain‐Herzberg
Angel Zarain‐Herzberg

20 November 2023 in Cell Calcium
Verified
Journal Article
Closed access
AHAndrés Hernández-Oliveras
Andrés Hernández-Oliveras
AZAngel Zarain-Herzberg
Angel Zarain-Herzberg

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JBJudith Bernal-Ramírez
Judith Bernal-Ramírez
CSChristian Silva-Platas
Christian Silva-Platas
CJCarlos Jerjes-Sánchez
Carlos Jerjes-Sánchez
MRMartin Ramos
Martin Ramos
EVEduardo Vázquez-Garza
Eduardo Vázquez-Garza
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vessel remodeling; however, its severity and impact on survival depend on right ventricular (RV) failure. Resveratrol (RES), a polyphenol found in red wine, exhibits cardioprotective effects on RV dysfunction in PAH. However, most literature has focused on RES protective effect on lung vasculature; recent finding indicates that RES has a cardioprotective effect independent of pulmonary arterial pressure on RV dysfunction, although the underlying mechanism in RV has not been determined. Therefore, this study is aimed at evaluating sirtuin‐3 (SIRT3) modulation by RES in RV using a monocrotaline‐ (MC‐) induced PAH rat model. Myocyte function was evaluated by confocal microscopy as cell contractility, calcium signaling, and mitochondrial membrane potential (ΔΨm); cell energetics was assessed by high‐resolution respirometry, and western blot and immunoprecipitation evaluated posttranslational modifications. PAH significantly affects mitochondrial function in RV; PAH is prone to mitochondrial permeability transition pore (mPTP) opening, thus decreasing the mitochondrial membrane potential. The compromised cellular energetics affects cardiomyocyte function by decreasing sarco‐endoplasmic reticulum Ca2+‐ATPase (SERCA) activity and delaying myofilament unbinding, disrupting cell relaxation. RES partially protects mitochondrial integrity by deacetylating cyclophilin‐D, a critical component of the mPTP, increasing SIRT3 expression and activity and preventing mPTP opening. The preserved energetic capability rescues cell relaxation by maintaining SERCA activity. Avoiding Ca2+ transient and cell contractility mismatch by preserving mitochondrial function describes, for the first time, impairment in excitation‐contraction‐energetics coupling in RV failure. These results highlight the importance of mitochondrial energetics and mPTP in PAH.